Reports Q3 revenue $5.2M, consensus $19.36M. Cash, cash equivalents and restricted cash were $667.1M as of September 30, compared to $603.0M as of December 31, 2024. “Recursion continues to deliver on ...
Lee May, diagnosed with aggressive multiple myeloma at 59, defied odds with cutting-edge treatments at UCSF Health, including ...
Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback